DOSSIER · UPDATED 18 NOV 2025

Spine BioPharma

Spine BioPharma develops a non-surgical solution for back pain that will eliminate pain and restore functionality.

spinebiopharma.com ↗Claim this profile
Founded
2015
Headcount
13
Open roles
0
Last raised
Undisclosed · $14M
SECTION I · THE BRIEF

Inside Spine BioPharma

Brief #64981Updated 18 NOV 2025NEW YORKMEDICAL ORGANIZATIONSUNDISCLOSED
Employbl Dossier

Spine BioPharma

Spine BioPharma develops a non-surgical solution for back pain that will eliminate pain and restore functionality.

Founded
2015
Headcount
13
Open roles
0
Last raised
Undisclosed · $14M
Section II · Premium ProfileMembers only
  • 01Engineering interview process at Spine BioPharmaLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked
Open Spine BioPharma briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Marc ViscogliosiMarc Viscogliosi
OPEN ROLES

Hiring at Spine BioPharma

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $67,709,256

Spine BioPharma Funding Rounds

  • Debt Financing

    $13,505,000

  • Undisclosed

    $13,505,000

  • Debt Financing

    $13,505,000

  • Undisclosed

    $13,505,000

  • Series Unknown

    $2,399,629

  • Debt Financing

    $2,399,629

  • Series Unknown

    $2,399,629

  • Debt Financing

    $2,399,629

  • Series Unknown

    $1,900,000

  • Series Unknown

    $1,900,000

  • Convertible Note

    $13,000,000

  • Convertible Note

    $13,000,000

    Convertible Note Investors

    Pacira
    Cercano Management
    Viscogliosi Brothers

  • Series B

    $13,000,000

  • Series B

    $13,000,000

    Series B Investors

    Cercano Management
    Pacira
    Viscogliosi Brothers

  • Convertible Note

    $3,000,000

  • Convertible Note

    $3,000,000

    Convertible Note Investors

    Pacira

  • Series A

    $5,000,000

  • Series A

    $5,000,000

    Series A Investors

    Viscogliosi Brothers
    Vulcan Capital
Funding info provided by Diffbot.
TAGS

Categorized in

Company Collections

These are collections Spine BioPharma is a part of. Click on the collection name to view similar companies.

Spine BioPharma's Industries

Spine BioPharma's Tech Stack

LOCATIONS

Where they work

Spine BioPharma Headquarters Location

505 Park Avenue 14th Floor, New York, NY, 10022

Loading map…